Kaiser Family Foundation. Copyright 2009 Advisory Table Kaiser and Company Family Foundation. All rights reserved.. American features series in HIV/AIDS: Prevention Strategies, MSM, Idus A Scientific American series examines how recent scientific advances will information future efforts to thwart HIV/Helps and also looks at the epidemic among men who have sex with men and injecting medication users . The same agents that were designed and developed to gradual the virus’s proliferation within our body today experienced the potential to be utilized to greatly help bar it from successfully setting up shop in the first place,’ Scientific American reports. To translate the findings of the microbicide avoidance trial ‘into something with real public-health impact, researchers need to confirm the results and address a long list of new queries introduced by them: What’s the very best dosage and focus? Could other ARV drugs do better? And the type of delivery system will best ensure that at-risk women actually use the preventive treatment?’ the magazine writes.Cerus keeps the commercialization rights for the INTERCEPT reddish colored blood cell system because of this area.08 per share, and Cerus shall relinquish its collateral interest in BioOne. We believe there is excellent market prospect of INTERCEPT in Asia and that regaining the platelet and plasma privileges from BioOne will allow us to go after a different business strategy and potential partnerships for all three programs, said Claes Glassell, Cerus’ president and chief executive officer.
BioTek wins Extraordinary New PRODUCTS award for Cytation 3 Cell Imaging Multi-Mode Reader BioTek Instruments, Inc., received Thermo Fisher Scientific's Extraordinary New PRODUCTS award for his or her Cytation 3 Cell Imaging Multi-Setting Reader.